Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology (IUST), Tehran, Iran.
Medical Nanotechnology and Tissue Engineering Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Sci Rep. 2022 May 19;12(1):8382. doi: 10.1038/s41598-022-12031-9.
Droplet microfluidic has been established to synthesize and functionalize micro/nanoparticles for drug delivery and screening, biosensing, cell/tissue engineering, lab-on-a-chip, and organ-on-a-chip have attracted much attention in chemical and biomedical engineering. Chitosan (CS) has been suggested for different biomedical applications due to its unique characteristics, such as antibacterial bioactivities, immune-enhancing influences, and anticancer bioactivities. The simulation results exhibited an alternative for attaining visions in this complex method. In this regard, the role of the flow rate ratio on the CS droplet features, including the generation rate and droplet size, were thoroughly described. Based on the results, an appropriate protocol was advanced for controlling the CS droplet properties for comparing their properties, such as the rate and size of the CS droplets in the microchip. Also, a level set (LS) laminar two-phase flow system was utilized to study the CS droplet-breaking process in the Flow Focused-based microchip. The outcomes demonstrated that different sizes and geometries of CS droplets could be established via varying the several parameters that validated addressing the different challenges for several purposes like drug delivery (the droplets with smaller sizes), tissue engineering, and cell encapsulation (the droplets with larger sizes), lab-on-a-chip, organ-on-a-chip, biosensing and bioimaging (the droplets with different sizes). An experimental study was added to confirm the simulation results. A drug delivery application was established to verify the claim.
液滴微流控技术已被用于合成和功能化微/纳米颗粒,用于药物输送和筛选、生物传感、细胞/组织工程、芯片实验室和器官芯片,在化学和生物医学工程中引起了广泛关注。壳聚糖 (CS) 因其独特的特性,如抗菌生物活性、免疫增强影响和抗癌生物活性,已被提议用于不同的生物医学应用。模拟结果为实现这种复杂方法中的愿景提供了一种替代方案。在这方面,详细描述了流速比对 CS 液滴特征(包括生成率和液滴尺寸)的影响。基于结果,提出了一种适当的方案来控制 CS 液滴的特性,以比较它们的特性,例如微芯片中 CS 液滴的速率和尺寸。此外,还利用层流两相流系统研究了基于流聚焦的微芯片中 CS 液滴破裂过程。结果表明,通过改变几个参数,可以形成不同尺寸和形状的 CS 液滴,这些参数已经验证可以解决不同目的的不同挑战,例如药物输送(较小尺寸的液滴)、组织工程和细胞封装(较大尺寸的液滴)、芯片实验室、器官芯片、生物传感和生物成像(不同尺寸的液滴)。增加了一项实验研究来验证模拟结果。建立了药物输送应用来验证这一说法。